Detalles de la búsqueda
1.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 390(14): 1265-1276, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38598794
2.
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Cancer
; 130(9): 1693-1701, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165808
3.
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer.
Cancer
; 130(4): 541-552, 2024 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37843249
4.
Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial.
Support Care Cancer
; 31(6): 321, 2023 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37148373
5.
A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Int J Mol Sci
; 24(21)2023 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958571
6.
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer.
Eur J Immunol
; 51(4): 956-964, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33506525
7.
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer.
Invest New Drugs
; 40(2): 265-273, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973117
8.
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.
Oncology
; 100(4): 228-237, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35196661
9.
Who is more likely to adopt and comply with the electronic patient-reported outcome measure (ePROM) mobile application? A real-world study with cancer patients undergoing active treatment.
Support Care Cancer
; 30(1): 659-668, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363495
10.
Development and Validation of Digital Health Technology Literacy Assessment Questionnaire.
J Med Syst
; 46(2): 13, 2022 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35072816
11.
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Cancer
; 127(16): 3019-3028, 2021 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826761
12.
MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.
Eur J Immunol
; 50(11): 1810-1819, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32510574
13.
Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer.
Breast Cancer Res Treat
; 189(3): 747-757, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34224056
14.
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
Nanomedicine
; 37: 102415, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34174421
15.
Patient-Reported Outcomes Measurement Information System: Translation and Linguistic Validation of Six Profile Domains for Korean Adults.
J Korean Med Sci
; 36(33): e212, 2021 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427060
16.
Genomic landscape of acquired resistance to third-generation EGFR tyrosine kinase inhibitors in EGFR T790M-mutant non-small cell lung cancer.
Cancer
; 126(11): 2704-2712, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32154925
17.
Biomarker-driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum-based chemotherapy.
Cancer
; 126(17): 4002-4012, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32584426
18.
Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer.
Breast Cancer Res Treat
; 184(2): 325-334, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32812178
19.
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
Invest New Drugs
; 38(2): 360-368, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31124056
20.
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
Jpn J Clin Oncol
; 50(5): 594-601, 2020 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32083304